WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Chemotherapy in Patients With Relapsed Small Cell Lung Cancer in Combination With Allopurinol and MycoPhenolate (CLAMP Trial)

Phase 1

Terminated

Conditions: Small-cell Lung Cancer
Small Cell Lung Carcinoma

Interventions: Drug: Mycophenolate Mofetil
Drug: Allopurinol
Drug: Irinotecan

First Posted Date: 2021-09-20

Last Posted Date: 2024-12-05

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 17

Registration Number: NCT05049863

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Imaging Apoptosis for Lymphoma Treatment Response

Early Phase 1

Terminated

Conditions: Diffuse Large B Cell Lymphoma

Interventions: Drug: 18F-FluorApoTrace

First Posted Date: 2021-09-17

Last Posted Date: 2024-05-30

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 12

Registration Number: NCT05048732

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Duvelisib Following Chimeric Antigen Receptor T-Cell Therapy

Phase 1

Recruiting

Conditions: Non-hodgkin Lymphoma
Acute Lymphocytic Leukemia

Interventions: Drug: Duvelisib

First Posted Date: 2021-09-14

Last Posted Date: 2024-11-05

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 43

Registration Number: NCT05044039

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Perioperative Outcome Risk Assessment With Computer Learning Enhancement

Not Applicable

Completed

Conditions: Acute Kidney Injury
Morality

Interventions: Other: Machine learning models predicting postoperative death and acute kidney injury

First Posted Date: 2021-09-13

Last Posted Date: 2022-11-14

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 5114

Registration Number: NCT05042804

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Ivosidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH1

Phase 2

Recruiting

Conditions: Clonal Cytopenia of Undetermined Significance

Interventions: Drug: Ivosidenib

First Posted Date: 2021-09-01

Last Posted Date: 2024-11-15

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 20

Registration Number: NCT05030441

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
🇺🇸
Northwell Health Cancer Institute (R.J. Zuckerberg Cancer Center), Lake Success, New York, United States
🇺🇸
Memorial Sloan Kettering, New York, New York, United States

and more 2 locations

Novel Optical Surface Image Guidance System for Beam-Gated Online Adaptive SBRT Delivery in Mobile Lower Lung and Upper Abdominal Malignancies

Not Applicable

Completed

Conditions: Any Solid Malignancies of Any Tissue Origin (Except for Small Cell Lung Cancer) Involving the Upper Abdomen and Thorax

Interventions: Device: ETHOS
Radiation: CT-guided stereotactic adaptive radiotherapy

First Posted Date: 2021-09-01

Last Posted Date: 2023-04-18

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 10

Registration Number: NCT05030454

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Assessing Effect of Withdrawal Time on Adenoma Detection Rate for Screening Colonoscopy

Not Applicable

Terminated

Conditions: Rectal Cancer
Colon Cancer
Colorectal Cancer

Interventions: Procedure: Colonoscopy 9 minute withdrawal
Procedure: Colonoscopy 12 minute withdrawal
Procedure: Colonoscopy with 6 minute withdrawal

First Posted Date: 2021-08-24

Last Posted Date: 2022-08-31

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 32

Registration Number: NCT05018325

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Comparing Intrathecal Morphine and Intraoperative Lidocaine Infusion to Epidural Anesthesia With Postoperative PCA for Patients Undergoing Exploratory Laparotomy

Phase 2

Recruiting

Conditions: Enlarged Uterus
Adnexal Mass
Fibroid Uterus
Cancer Debulking

Interventions: Drug: Bupivacaine
Drug: Morphine
Drug: Lidocaine

First Posted Date: 2021-08-23

Last Posted Date: 2024-05-23

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 174

Registration Number: NCT05017246

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Open-label MNS for Tourette Syndrome

Not Applicable

Completed

Conditions: Tic Disorder, Chronic Motor or Vocal
Tourette Syndrome

Interventions: Device: Active, self-directed electrical stimulation of the median nerve

First Posted Date: 2021-08-23

Last Posted Date: 2023-10-05

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 31

Registration Number: NCT05016765

Locations: 🇺🇸
Washington University School of Medicine, Movement Disorders Center, Saint Louis, Missouri, United States

Transgender Estradiol Affirming Therapy

Phase 2

Completed

Conditions: Transgenderism

Interventions: Diagnostic Test: Pro-thrombotic markers
Drug: Transdermal patch
Diagnostic Test: Metabolic markers
Diagnostic Test: Hormone Profile
Drug: Daily Sublingual Tablet
Drug: BID Sublingual Tablet
Drug: Spironolactone

First Posted Date: 2021-08-18

Last Posted Date: 2024-11-26

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 39

Registration Number: NCT05010707

Locations: 🇺🇸
Washington University Transgender Center, Saint Louis, Missouri, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy